Literature DB >> 20210361

Effect of lipid type on the binding of lipid vesicles to islet amyloid polypeptide amyloid fibrils.

Kenji Sasahara1, Damien Hall, Daizo Hamada.   

Abstract

Amyloid deposits, composed primarily of the 37-residue islet amyloid polypeptide (IAPP), are observed near pancreatic beta-cells of type II diabetics, with their presence strongly correlating with a loss of beta-cell mass and decreased pancreatic function. Although beta-cell membranes have been implicated as the likely target of amyloidogenic IAPP toxicity, interactions between membranes and IAPP in the fibrillar state have not been well characterized. In this study, turbidity measurements were conducted to provide a detailed description of the binding reaction between IAPP fibrils and lipid vesicles made from phosphatidylcholine. The kinetic data representing the rate and extent of the fibril-vesicle binding reaction are described well by an empirical double-exponential equation. The extent of binding was found to increase with increasing amyloid fibril concentration. Modification of the vesicle composition significantly altered the observed binding reaction kinetics, with the change quantified using the parameters obtained from the double-exponential fitting analysis. When the vesicles contained a significant amount of the lipid phosphatidylglycerol, substantial sedimentation of the vesicles under gravity was detected following the initial binding reaction. To rationalize the observed kinetic binding data, we developed a mesoscopic simulation model based on a hard particle representation of the species involved. In light of the observed data and simulation predictions, the potential roles of IAPP amyloid fibrils in membrane binding are discussed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20210361     DOI: 10.1021/bi9019252

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Revealing a Dual Role of Ganglioside Lipids in the Aggregation of Membrane-Associated Islet Amyloid Polypeptide.

Authors:  Mikkel Christensen; Birgit Schiøtt
Journal:  J Membr Biol       Date:  2019-06-20       Impact factor: 1.843

2.  2DIR spectroscopy of human amylin fibrils reflects stable β-sheet structure.

Authors:  Lu Wang; Chris T Middleton; Sadanand Singh; Allam S Reddy; Ann M Woys; David B Strasfeld; Peter Marek; Daniel P Raleigh; Juan J de Pablo; Martin T Zanni; James L Skinner
Journal:  J Am Chem Soc       Date:  2011-09-15       Impact factor: 15.419

Review 3.  Membrane-mediated amyloid deposition of human islet amyloid polypeptide.

Authors:  Kenji Sasahara
Journal:  Biophys Rev       Date:  2017-12-04

4.  Cations as switches of amyloid-mediated membrane disruption mechanisms: calcium and IAPP.

Authors:  Michele F M Sciacca; Danilo Milardi; Grazia M L Messina; Giovanni Marletta; Jeffrey R Brender; Ayyalusamy Ramamoorthy; Carmelo La Rosa
Journal:  Biophys J       Date:  2013-01-08       Impact factor: 4.033

5.  Direct three-dimensional visualization of membrane disruption by amyloid fibrils.

Authors:  Lilia Milanesi; Tania Sheynis; Wei-Feng Xue; Elena V Orlova; Andrew L Hellewell; Raz Jelinek; Eric W Hewitt; Sheena E Radford; Helen R Saibil
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

6.  Amylin analogues in the treatment of diabetes mellitus: medicinal chemistry and structural basis of its function.

Authors:  Ernest Adeghate; Huba Kalász
Journal:  Open Med Chem J       Date:  2011-09-09

7.  On the nature of the optimal form of the holdase-type chaperone stress response.

Authors:  Damien Hall
Journal:  FEBS Lett       Date:  2019-09-21       Impact factor: 3.864

Review 8.  Measurement of amyloid formation by turbidity assay-seeing through the cloud.

Authors:  Ran Zhao; Masatomo So; Hendrik Maat; Nicholas J Ray; Fumio Arisaka; Yuji Goto; John A Carver; Damien Hall
Journal:  Biophys Rev       Date:  2016-11-23

Review 9.  Mechanisms Underlying the Antidiabetic Activities of Polyphenolic Compounds: A Review.

Authors:  Tina Nie; Garth J S Cooper
Journal:  Front Pharmacol       Date:  2021-12-14       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.